2 Top Dividend Kings to Buy for the Long Haul
Johnson & Johnson (NYSE: JNJ) and Becton, Dickinson (NYSE: BDX) are set-it-and-forget-it dividend stocks in the healthcare sector. By that, I mean these companies, both of which were founded in the late 1800s, are Dividend Kings that have raised their dividends for 50 or more straight years -- the very definition of dependable.
They are huge, mature companies, so it's unlikely for them to have explosive revenue growth, but rather, a steady consistent rise that makes them attractive long-term holds for investors. It's not that these companies aren't affected by the vicissitudes of the market, but they have the financial depth to overcome obstacles such as lawsuits, supply chain issues and the like.
Johnson & Johnson stock is down only a little more than 1% this year while the S&P 500 is off more than 19%. In its most recent quarterly release, the company reported second-quarter revenue of $24 billion, up 3% year over year and earnings per share (EPS) of $1.80, down 24% over the same period in 2021. The company's guidance puts annual revenue between $97.3 billion and $98.3 billion, up between 6.5% and 7.5% over 2021. J&J also said it expects yearly adjusted EPS of between $10 and $10.10, up 2.1% to 3.1%, year over year.
Source Fool.com
